McGowan Group Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-158,507
| Closed | -$18.9M | – | 133 |
|
|
2024
Q3 | $18.9M | Sell |
158,507
-69,970
| -31% | -$8.33M | 2.49% | 12 |
|
|
2024
Q2 | $32.6M | Buy |
228,477
+1,289
| +0.6% | +$184K | 4.54% | 6 |
|
|
2024
Q1 | $29.2M | Sell |
227,188
-1,136
| -0.5% | -$146K | 4.21% | 8 |
|
|
2023
Q4 | $23.6M | Sell |
228,324
-2,474
| -1% | -$256K | 3.79% | 8 |
|
|
2023
Q3 | $21M | Buy |
+230,798
| New | +$21M | 3.31% | 8 |
|